Johnson & Johnson Announces Apple Watch Study to Improve AFib Outcomes Including Stroke Prevention

Johnson & Johnson Announces Apple Watch Study to Improve AFib Outcomes Including Stroke Prevention

Posted by · 4486 views · Translate

Johnson & Johnson has announced that their Janssen Pharmaceuticals company has entered into a research study with Apple to investigate whether a new heart health program used in combination with the Apple Watch can accelerate the diagnosis and improve health outcomes for people with atrial fibrillation (AFib).

The study aims to analyze the impact of Apple Watch on the early detection and diagnosis of AFib, and the potential to improve outcomes including the prevention of stroke. A multi-year research program will be launched later in 2019. This large-scale program will occur in the U.S. only, and will be designed as a pragmatic randomized controlled research study for individuals age 65 years or older.

The study's goals include:
● Measuring the outcomes of a heart health engagement program with irregular rhythm notifications on Apple Watch.
● Assessing the impact of a medication adherence program using an app from Johnson & Johnson.

"We're excited about the potential of common, wearable technology to aid in the earlier detection and prevention of a frequent cause of stroke," said Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "Too many people living with AFib are unaware of their risk, and earlier detection, diagnosis and treatment of AFib could significantly improve outcomes. Based on the insights generated through this research program, we may be able to develop new ways to detect other health conditions earlier in the future that also exhibit measurable physiological symptoms."

"Through Apple Watch people have been able to learn more about their heart health, including discovering they have AFib. This kind of information empowers customers to follow up with the right treatment or even better, implement healthy habits aimed at prevention," said Jeff Williams, Chief Operating Officer, Apple Inc. "We're excited to work with Johnson & Johnson, a leader in the medical community, as we learn about the impact Apple Watch can have in delivering better health outcomes."

The ability to take an ECG requires a new Apple Watch Series 4 which starts at $399. It's not possible to take an ECG with earlier generation Apple Watches; however, earlier models can give you important information about your heart rate.


Johnson & Johnson Announces Apple Watch Study to Improve AFib Outcomes Including Stroke Prevention

Recent